The study shows that patients with psoriasis have increased plasma levels of IL-1β and IL-18 and increased constitutive expression of the inflammasome sensors NLRP3, NLRP1, and AIM2 in peripheral blood cells, together with increased caspase 1 reactivity [88]. This evidence concerns the gene AIM2 and psoriasis.